{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:40:02Z","timestamp":1765806002795},"reference-count":114,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T00:00:00Z","timestamp":1651536000000},"content-version":"am","delay-in-days":397,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.ando.2021.03.005","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:12:29Z","timestamp":1617883949000},"page":"112-120","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["New therapies for patients with multiple endocrine neoplasia type 1"],"prefix":"10.1016","volume":"82","author":[{"given":"Aurore","family":"Geslot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magaly","family":"Vialon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Caron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solange","family":"Grunenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Delphine","family":"Vezzosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ando.2021.03.005_bib0575","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2021.03.005_bib0580","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","author":"Brandi","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0585","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddt039","article-title":"Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d\u2019\u00e9tude des Tumeurs Endocrines (GTE) cohort study","volume":"22","author":"Thevenon","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ando.2021.03.005_bib0590","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00268-017-4435-3","article-title":"From initial description by Wermer to present-day MEN1: what have we learned?","volume":"42","author":"Perrier","year":"2018","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0595","doi-asserted-by":"crossref","first-page":"E2387","DOI":"10.1210\/jc.2013-4432","article-title":"Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain","volume":"99","author":"Bartsch","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0600","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.surg.2017.04.044","article-title":"Genotype-phenotype pancreatic neuroendocrine tumor relationship in multiple endocrine neoplasia type 1 patients: a 23-year experience at a single institution","volume":"163","author":"Christakis","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib0605","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00268-009-0290-1","article-title":"Risk factors and causes of death in MEN1 disease. A GTE (Groupe d\u2019\u00c9tude des Tumeurs Endocrines) cohort study among 758 patients","volume":"34","author":"Goudet","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0610","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1002\/bjs.7154","article-title":"Surgery for multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"97","author":"Waldmann","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0615","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJM199908263410902","article-title":"Surgery to cure the Zollinger-Ellison syndrome","volume":"341","author":"Norton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2021.03.005_bib0620","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.sla.0000218073.77254.62","article-title":"Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias","volume":"244","author":"Tonelli","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0625","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1210\/jc.2014-3659","article-title":"MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019\u00c9tude des Tumeurs Endocrines","volume":"100","author":"Goudet","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0630","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0635","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.md.0000112297.72510.32","article-title":"Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature","volume":"83","author":"Gibril","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ando.2021.03.005_bib0640","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.surg.2017.07.023","article-title":"Disease and treatment factors associated with lower quality of life scores in adults with multiple endocrine neoplasia type I","volume":"162","author":"Goswami","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib0645","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12020-017-1322-5","article-title":"MEN1 in children and adolescents: data from patients of a regional referral center for hereditary endocrine tumors","volume":"59","author":"Vannucci","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2021.03.005_bib0650","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3389\/fendo.2018.00597","article-title":"When parathyroidectomy should be indicated or postponed in adolescents with MEN1-related primary hyperparathyroidism","volume":"9","author":"Marini","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2021.03.005_bib0655","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/jbmr.125","article-title":"Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"25","author":"Lourenco","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2021.03.005_bib0660","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archsurg.134.10.1119","article-title":"Osteoporosis in multiple endocrine neoplasia type 1: severity, clinical significance, relationship to primary hyperparathyroidism, and response to parathyroidectomy","volume":"134","author":"Burgess","year":"1999","journal-title":"Arch Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0665","doi-asserted-by":"crossref","first-page":"99","DOI":"10.6061\/clinics\/2012(Sup01)17","article-title":"Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1","volume":"67","author":"Lourenco","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.ando.2021.03.005_bib0670","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.surg.2016.06.065","article-title":"Operative intervention for primary hyperparathyroidism offers greater bone recovery in patients with sporadic disease than in those with multiple endocrine neoplasia type 1-related hyperparathyroidism","volume":"161","author":"Silva","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib0675","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jamasurg.2016.2310","article-title":"The American Association of Endocrine Surgeons Guidelines for definitive management of primary hyperparathyroidism","volume":"151","author":"Wilhelm","year":"2016","journal-title":"JAMA Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0680","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0685","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00268-010-0605-2","article-title":"Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1","volume":"34","author":"Salmeron","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0690","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1097\/MNM.0000000000000595","article-title":"Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands","volume":"37","author":"Kluijfhout","year":"2016","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.ando.2021.03.005_bib0695","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fendo.2019.00123","article-title":"Could the less-than subtotal parathyroidectomy be an option for treating young patients with multiple endocrine neoplasia type 1-related hyperparathyroidism?","volume":"10","author":"Montenegro","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ando.2021.03.005_bib0700","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/cen.14112","article-title":"Single gland excision for MEN1-associated primary hyperparathyroidism","volume":"92","author":"Manoharan","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2021.03.005_bib0705","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/s41598-020-67424-5","article-title":"Benefit of diverse surgical approach on short-term outcomes of MEN1-related hyperparathyroidism","volume":"10","author":"Choi","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ando.2021.03.005_bib0710","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1245\/s10434-015-4865-9","article-title":"Limited parathyroidectomy in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism: a setup for failure","volume":"23","author":"Nilubol","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2021.03.005_bib0715","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1007\/s00268-016-3624-9","article-title":"Unilateral clearance for primary hyperparathyroidism in selected patients with multiple endocrine neoplasia type 1","volume":"40","author":"Kluijfhout","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0720","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1245\/s10434-016-5467-x","article-title":"Reoperative surgery in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism","volume":"23","author":"Keutgen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2021.03.005_bib0725","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1007\/s00268-020-05695-9","article-title":"(18)F-fluorocholine PET\/CT in MEN1 patients with primary hyperparathyroidism","volume":"44","author":"Gauthe","year":"2020","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0730","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1507\/endocrj.K09E-204","article-title":"Surgical approach in hereditary hyperparathyroidism","volume":"56","author":"Tonelli","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/j.ando.2021.03.005_bib0735","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s00268-011-1068-9","article-title":"The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review","volume":"35","author":"Schreinemakers","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0740","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2021.03.005_bib0745","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1210\/jc.2014-3255","article-title":"Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1","volume":"100","author":"Singh Ospina","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0750","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1067\/msy.1998.91826","article-title":"Indications, technique, and efficacy of alcohol injection of enlarged parathyroid glands in patients with primary hyperparathyroidism","volume":"124","author":"Harman","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib0755","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s003300050587","article-title":"Percutaneous ethanol injection into parathyroid adenomas: mid- and long-term results","volume":"8","author":"Cercueil","year":"1998","journal-title":"Eur Radiol"},{"key":"10.1016\/j.ando.2021.03.005_bib0760","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/eje.1.01901","article-title":"Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies","volume":"152","author":"Vezzosi","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.03.005_bib0765","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1136\/pgmj.73.864.640","article-title":"Diazoxide treatment for insulinoma: a national UK survey","volume":"73","author":"Gill","year":"1997","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ando.2021.03.005_bib0770","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/cen.13961","article-title":"Medical therapy in patients with endogenous hypoglycaemia: is euglycaemia achievable?","volume":"90","author":"Vezzosi","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2021.03.005_bib0775","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3748\/wjg.v17.i10.1343","article-title":"Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients","volume":"17","author":"Imamura","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ando.2021.03.005_bib0780","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/SLA.0b013e3182536339","article-title":"Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1","volume":"257","author":"Lopez","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0785","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000003162","article-title":"Metastatic potential and survival of duodenal and pancreatic tumors in multiple endocrine neoplasia type 1: a GTE and AFCE cohort study (Groupe d\u2019\u00e9tude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)","volume":"272","author":"Vinault","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0790","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0016-5085(99)70124-1","article-title":"Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Groupe d\u2019\u00c9tude des Neoplasies Endocriniennes Multiples (GENEM) and Groupe de Recherche et d\u2019\u00c9tude du Syndrome de Zollinger-Ellison (GRESZE)","volume":"116","author":"Cadiot","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2021.03.005_bib0795","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00000658-200110000-00009","article-title":"Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome","volume":"234","author":"Norton","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0800","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(95)90124-8","article-title":"Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study","volume":"108","author":"Weber","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ando.2021.03.005_bib0805","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.2169\/internalmedicine.49.3607","article-title":"Long-term suppressive effect of octreotide on progression of metastatic gastrinoma with multiple endocrine neoplasia type 1: seven-year follow-up","volume":"49","author":"Yamaguchi","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.ando.2021.03.005_bib0810","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1056\/NEJM199003153221103","article-title":"Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome","volume":"322","author":"Pipeleers-Marichal","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2021.03.005_bib0815","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2796.1998.00307.x","article-title":"Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both","volume":"243","author":"Thompson","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2021.03.005_bib0820","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199409000-00008","article-title":"Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma","volume":"220","author":"Fraker","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0825","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.surg.2011.09.028","article-title":"Achieving eugastrinemia in MEN1 patients: both duodenal inspection and formal lymph node dissection are important","volume":"150","author":"Dickson","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib0830","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jamcollsurg.2006.02.013","article-title":"et al., 50-year appraisal of gastrinoma: recommendations for staging and treatment","volume":"202","author":"Ellison","year":"2006","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0835","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1097\/01.sla.0000246951.21252.60","article-title":"An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors","volume":"244","author":"Fendrich","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0840","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/BF01655105","article-title":"Surgical treatment of the Zollinger-Ellison syndrome","volume":"17","author":"Stadil","year":"1993","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0845","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1210\/jc.2007-0283","article-title":"Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome","volume":"92","author":"Schott","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0850","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00268-004-7345-0","article-title":"Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas","volume":"28","author":"Richards","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0855","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.jamcollsurg.2007.06.320","article-title":"Role of surgery in Zollinger-Ellison syndrome","volume":"205","author":"Norton","year":"2007","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0860","doi-asserted-by":"crossref","first-page":"101318","DOI":"10.1016\/j.beem.2019.101318","article-title":"Contemporary surgical management of the Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1","volume":"33","author":"Albers","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0865","article-title":"Multiple endocrine neoplasia type 1 (MEN1) and the pancreas\u00a0\u2013\u00a0diagnosis and treatment of functioning and nonfunctioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome\u00a0\u2013\u00a0An international consensus statement","author":"Niederle","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2021.03.005_bib0870","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S2213-8587(15)00043-1","article-title":"Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1","volume":"3","author":"Yates","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2021.03.005_bib0875","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/SLA.0000000000002191","article-title":"Long-term follow-up of MEN1 patients who do not have initial surgery for small \u2264 2 cm nonfunctioning pancreatic neuroendocrine tumors, an AFCE and GTE Study: Association Francophone de Chirurgie Endocrinienne & Groupe d\u2019\u00c9tude des Tumeurs Endocrines","volume":"268","author":"Triponez","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0880","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/SLA.0000000000002183","article-title":"Management of MEN1-related nonfunctioning pancreatic NETs: a shifting paradigm: results from the DutchMEN1 Study Group","volume":"267","author":"Nell","year":"2018","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0885","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/01.sla.0000197715.96762.68","article-title":"Epidemiology data on 108 MEN 1 patients from the GTE with isolated nonfunctioning tumors of the pancreas","volume":"243","author":"Triponez","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0890","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/SLA.0000000000003162","article-title":"Metastatic potential and survival of duodenal and pancreatic tumors in multiple endocrine neoplasia type 1: a GTE and AFCE Cohort Study (Groupe d\u2019\u00e9tude des Tumeurs Endocrines and Association Francophone de Chirurgie Endocrinienne)","volume":"272","author":"Vinault","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0895","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/cen.13264","article-title":"Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours","volume":"86","author":"Donegan","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2021.03.005_bib0900","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(15)00186-2","article-title":"Consensus on biomarkers for neuroendocrine tumour disease","volume":"16","author":"Oberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ando.2021.03.005_bib0905","first-page":"105","article-title":"Lanreotide therapy vs. active surveillance in MEN1-related pancreatic neuroendocrine tumors < 2 centimeters","author":"Faggiano","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0910","doi-asserted-by":"crossref","first-page":"148","DOI":"10.6004\/jnccn.2006.0015","article-title":"Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1","volume":"4","author":"Norton","year":"2006","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ando.2021.03.005_bib0915","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/BF00353743","article-title":"Surgical management of insulinoma associated with multiple endocrine neoplasia type I","volume":"18","author":"O\u2019Riordain","year":"1994","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0920","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.surg.2016.09.017","article-title":"Operation for insulinomas in multiple endocrine neoplasia type 1: when pancreatoduodenectomy is appropriate","volume":"161","author":"Tonelli","year":"2017","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib0925","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000443171","article-title":"ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors","volume":"103","author":"Falconi","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2021.03.005_bib0930","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/bjs.11632","article-title":"Surgery for multiple endocrine neoplasia type 1-related insulinoma: long-term outcomes in a large international cohort","volume":"107","author":"van Beek","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0935","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1530\/EJE-14-0878","article-title":"Long-term results of the surgical management of insulinoma patients with MEN1: a Groupe d\u2019\u00e9tude des Tumeurs Endocrines (GTE) retrospective study","volume":"172","author":"Vezzosi","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.03.005_bib0940","first-page":"998","article-title":"Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach","volume":"110","author":"Demeure","year":"1991","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib0945","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000357779","article-title":"Enucleation and limited pancreatic resection provide long-term cure for insulinoma in multiple endocrine neoplasia type 1","volume":"98","author":"Bartsch","year":"2013","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ando.2021.03.005_bib0950","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/PAS.0b013e3181874eca","article-title":"Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia","volume":"33","author":"Anlauf","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2021.03.005_bib0955","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1001\/archsurg.1985.01390290062010","article-title":"Surgical management of hyperinsulinism in the multiple endocrine neoplasia, type 1 syndrome","volume":"120","author":"Rasbach","year":"1985","journal-title":"Arch Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0960","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9610(98)00012-9","article-title":"Surgical strategy for insulinomas in multiple endocrine neoplasia type I","volume":"175","author":"Lo","year":"1998","journal-title":"Am J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0965","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1072-7515(99)00162-3","article-title":"A personal experience with pancreatic and duodenal neuroendocrine tumors","volume":"189","author":"Jordan","year":"1999","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0970","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/jso.24315","article-title":"Robot-assisted spleen preserving pancreatic surgery in MEN1 patients","volume":"114","author":"Nell","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ando.2021.03.005_bib0975","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s00268-016-3456-7","article-title":"Minimally invasive versus open pancreatic surgery in patients with multiple endocrine neoplasia type 1","volume":"40","author":"Lopez","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib0980","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1210\/jc.2019-01204","article-title":"Surgical management, preoperative tumor localization, and histopathology of 80 patients operated on for insulinoma","volume":"104","author":"Andreassen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib0985","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41591-019-0493-4","article-title":"Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors","volume":"25","author":"Cejas","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.ando.2021.03.005_bib0990","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2967\/jnumed.115.157768","article-title":"Localization of hidden insulinomas with (6)(8)Ga-DOTA-Exendin-4 PET\/CT: a pilot study","volume":"56","author":"Antwi","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ando.2021.03.005_bib0995","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/RLU.0000000000003093","article-title":"Detection of insulinomas using dual-time-point 68Ga-DOTA-Exendin 4 PET\/CT","volume":"45","author":"Michalski","year":"2020","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ando.2021.03.005_bib1000","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1097\/RLU.0000000000002522","article-title":"Volume replacement fluid demarks benign insulinoma with 68Ga-DOTA-Exendin-4 PET\/CT","volume":"44","author":"Antwi","year":"2019","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.ando.2021.03.005_bib1005","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1210\/jc.2019-00282","article-title":"Endoscopic ultrasound-guided radiofrequency ablation: a new therapeutic approach for pancreatic neuroendocrine tumors","volume":"104","author":"Oleinikov","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib1010","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1055\/a-0824-7067","article-title":"Endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine tumors and pancreatic cystic neoplasms: a prospective multicenter study","volume":"51","author":"Barthet","year":"2019","journal-title":"Endoscopy"},{"key":"10.1016\/j.ando.2021.03.005_bib1015","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1097\/MEG.0b013e328323d70e","article-title":"Radiofrequency ablation of solitary pancreatic insulinoma in a patient with episodes of severe hypoglycemia","volume":"21","author":"Limmer","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.ando.2021.03.005_bib1020","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1097\/SLE.0b013e318264b607","article-title":"Laparoscopic radiofrequency ablation of functioning pancreatic insulinoma: video case report","volume":"22","author":"Prochazka","year":"2012","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10.1016\/j.ando.2021.03.005_bib1025","doi-asserted-by":"crossref","first-page":"E144","DOI":"10.1055\/s-0042-104650","article-title":"Successful management of a sporadic pancreatic insulinoma by endoscopic ultrasound-guided radiofrequency ablation","volume":"48","author":"Waung","year":"2016","journal-title":"Endoscopy"},{"key":"10.1016\/j.ando.2021.03.005_bib1030","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gie.2015.08.085","article-title":"EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos)","volume":"83","author":"Lakhtakia","year":"2016","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.ando.2021.03.005_bib1035","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/den.12866","article-title":"Small pancreatic insulinoma: successful endoscopic ultrasound-guided radiofrequency ablation in a single session using a 22-G fine needle","volume":"29","author":"Bas-Cutrina","year":"2017","journal-title":"Dig Endosc"},{"key":"10.1016\/j.ando.2021.03.005_bib1040","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s13304-016-0388-6","article-title":"Are there still indications for total pancreatectomy?","volume":"68","author":"Del Chiaro","year":"2016","journal-title":"Updates Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib1045","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1245\/s10434-019-07853-3","article-title":"Impact of endocrine and exocrine insufficiency on quality of life after total pancreatectomy","volume":"27","author":"Stoop","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ando.2021.03.005_bib1050","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.surg.2007.09.010","article-title":"Pancreatoduodenal surgery in patients with multiple endocrine neoplasia type 1: operative outcomes, long-term function, and quality of life","volume":"142","author":"You","year":"2007","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2021.03.005_bib1055","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1007\/s00268-019-05107-7","article-title":"One-year postoperative mortality in MEN1 patients operated on gastric and duodenopancreatic neuroendocrine tumors: an AFCE and GTE cohort study","volume":"43","author":"Christou","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib1060","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1210\/jcem.86.11.8011","article-title":"Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form","volume":"86","author":"Gibril","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib1065","first-page":"4776","article-title":"Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1","volume":"85","author":"Stratakis","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib1070","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12020-017-1234-4","article-title":"Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database","volume":"58","author":"Giusti","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2021.03.005_bib1075","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/JC.2015-2015","article-title":"Long-term natural course of pituitary tumors in patients with MEN1: results from the DutchMEN1 Study Group (DMSG)","volume":"100","author":"de Laat","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib1080","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00006123-199608000-00008","article-title":"Results of treatment of pituitary disease in multiple endocrine neoplasia, type I","volume":"39","author":"O\u2019Brien","year":"1996","journal-title":"Neurosurgery"},{"key":"10.1016\/j.ando.2021.03.005_bib1085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1210\/jcem.87.2.8145","article-title":"Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study","volume":"87","author":"Verges","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib1090","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0b013e31815ade45","article-title":"Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients","volume":"32","author":"Trouillas","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.ando.2021.03.005_bib1095","doi-asserted-by":"crossref","first-page":"T179","DOI":"10.1530\/ERC-17-0225","article-title":"The future: medical advances in MEN1 therapeutic approaches and management strategies","volume":"24","author":"van Leeuwaarde","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ando.2021.03.005_bib1100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2796.1998.00275.x","article-title":"Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1","volume":"243","author":"Burgess","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.ando.2021.03.005_bib1105","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/EJE-10-0950","article-title":"Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d\u2019\u00e9tude des Tumeurs Endocrines","volume":"165","author":"Goudet","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2021.03.005_bib1110","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ando.2021.03.005_bib1115","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1365-2265.2011.04227.x","article-title":"Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database","volume":"76","author":"Sakurai","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2021.03.005_bib1120","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1007\/s00268-009-9980-y","article-title":"Thymic neuroendocrine tumors in multiple endocrine neoplasia type 1: a comparative study on 21 cases among a series of 761 MEN1 from the GTE (Groupe des Tumeurs Endocrines)","volume":"33","author":"Goudet","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib1125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00000658-199807000-00015","article-title":"Thymic carcinoids in multiple endocrine neoplasia type 1","volume":"228","author":"Teh","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.ando.2021.03.005_bib1130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1406028","article-title":"Breast cancer predisposition in multiple endocrine neoplasia type 1","volume":"371","author":"Dreijerink","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2021.03.005_bib1135","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1210\/jc.2016-3690","article-title":"MEN1-dependent breast cancer: indication for early screening? Results from the Dutch MEN1 Study Group","volume":"102","author":"van Leeuwaarde","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2021.03.005_bib1140","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jc.2018-00259","article-title":"High fear of disease occurrence is associated with low quality of life in patients with multiple endocrine neoplasia type 1: results from the Dutch MEN1 Study Group","volume":"103","author":"van Leeuwaarde","year":"2018","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426621000305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426621000305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T17:07:07Z","timestamp":1698858427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426621000305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":114,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0003426621000305"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2021.03.005","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapies for patients with multiple endocrine neoplasia type 1","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2021.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}